Catalyst Wire Dossier Catalyst Wire Dossier

ASP8477

· Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP8477, covering 2014-08-20 to 2017-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety [Phase 2]

See pricing